期刊文献+

结肠癌中骨形成蛋白-6启动子异常甲基化 被引量:1

Hypermethylation of BMP-6 in human colorectal carcinoma
下载PDF
导出
摘要 目的研究骨形成蛋白-6(BMP-6)启动子在结肠癌细胞中的甲基化状态。方法运用甲基化特异PCR(MSP)法检测30例原发结肠癌和癌旁组织中BMP-6的甲基化水平。甲基化修饰后亚硫酸盐测序PCR(BSP)分析结肠癌细胞COLO-205细胞BMP-6启动子CpG岛甲基化状态。提取细胞RNA,通过实时定量PCR(real time-PCR)检测BMP-6 mRNA在不同浓度的DNA甲基化酶抑制剂5’-杂氮-2’-脱氧胞嘧啶(5-aza-dC)处理COLO-205细胞后BMP-6 mRNA的改变情况。结果原发性结肠癌的甲基化异常检出率是33.3%(10/30)。BMP-6在COLO-205细胞中存在高甲基化状态,COLO-205细胞经5-aza-dC处理后BMP-6 mRNA表达明显上调。结论BMP-6在原发性结肠癌中存在甲基化异常,说明BMP-6基因甲基化异常可能参与结肠癌的发生。 Objective To detect the methylation status of BMP-6 promoter in colorectal carcinoma (CRC)cells. Methods Thirty primary CRC tissues and corresponding normal tissues were detected by Methylationspecific PCR (MSP) method. Methylation status of BMP-6 promoter in CRC cell line COLO-205 was detected by Bisulfite-sequencing PCR (BSP). And the expression of BMP-6 in COLO-205 or cells treated with increasing mount of demethylation agent, 5- aza-dC was identified by RT-PCR. Results Aberrant methylation in primary CRC was 33.3% (10/30). Hypermethylation of BMP-6 was observed in COLO-205 cells. Increased BMP-6 mRNA can be restored in COLO-205 after treatment with 5-aza-dC. Conclusion The promoter hypermethylation of BMP-6 may play an important role in tumorigenesis of CRC.
出处 《胃肠病学和肝病学杂志》 CAS 2009年第6期535-537,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 结肠癌细胞 骨形成蛋白-6 DNA高甲基化 '5-杂氮-2’-脱氰胞嘧啶(5-aza-dC) Colorectal carcinoma BMP-6 Hypermethylation 5-aza-dC
  • 相关文献

参考文献9

  • 1Kraunz KS, Nelson HH, Liu M, et al. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in tung cancer [J]. Br J Cancer, 2005, 93(8): 949-952.
  • 2Daibata M, Nemoto Y, Bandobashi K, et al. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma [J]. Clin Cancer Res, 2007, 13(12): 3528-3535.
  • 3Tamada H, Kitazawa R, Gohji K, et al. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer [J]. J Bone Miner Res, 2001, 16(3): 487-496.
  • 4Haudenschild DR, Palmer SM, Moseley TA, et al. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer [J]. Cancer Res, 2004, 64(22): 8276-8284.
  • 5Wach S, Schirmacher P, Protschka M, et al. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members [J]. Oncozene. 2001. 20(53): 7761-7769.
  • 6Kim IY, Lee DH, Lee DK, et al. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells [ J]. Clin Cancer Res, 2003, 9(16 Pt 1 ) : 6046-6051.
  • 7Zhang M, Wang Q, Yuan W, et al. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells [ J]. J Steroid Biochem Mol Biol, 2007, 105(1-5) : 91-97.
  • 8Ro TB, Holt RU, Brenne AT, et al. Bone morphogenetic protein-5, - 6 and -7 inhibit growth and induce apoptosis in human myeloma cells [ J ]. Oncogene, 2004, 23 (17) : 3024-3032.
  • 9Taniguchi A, Nemoto Y, Yokoyama A, et al. Promoter methylation of the bone morphogenetic protein45 gene in association with adult T-cell leUkemia [J]. lnt J Cancer, 2008, 123(8): 1824-1831.

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部